Abstract
Large cohort studies showing health impacts of vegetarianism have not considered differences in genetics. We designed a rigorous definition of vegetarianism using data from two surveys in the UK Biobank to identify a reliable cohort of vegetarians. Vegetarians were matched 1:4 with non-vegetarians, revealing significant effects of vegetarianism in 15 of 30 serum biomarkers. Notably, all cholesterol measures plus Vitamin D (P = 2.1e-49) were significantly lower in vegetarians, while triglycerides were higher (P = 4.0e-26). We performed a genome-wide association study and found no significant associations with vegetarianism as a trait. Finally, we performed the first ever genome-wide gene-vegetarianism interaction analyses for 30 biomarker traits (N = 147,253). We detected evidence of gene-vegetarianism interaction with one genome-wide significant variant at rs72952628 (P = 4.47e-08), where the heterozygous genotype was associated with higher calcium in vegetarians. rs72952628 is located in MMAA, which is part of the B12 metabolism pathway; B12 has a high deficiency potential in vegetarians. Gene-based aggregation of interaction P-values revealed two additional significant genes, RNF168 in testosterone (P = 1.45e-06), and DOCK4 in eGFR (P = 6.76e-07), which have previously been associated with testicular and renal traits, respectively. These nutrigenetic findings suggest differences in genotype may play a role in moderating the benefits a vegetarian diet.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institute of Health under award numbers T32GM007103 (MF) and R35GM143060 (KY). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRB of University of Georgia gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Full and annotated code used in this analysis, gene-level summary statistics, and interactive Manhattan plots are publicly available at https://michaelofrancis.github.io/VegetarianGDI/. Summary statistics for GWAS and GWIS at GWAS Catalog (https://www.ebi.ac.uk/gwas/). The corresponding accession numbers can be found in Supplementary table S5.
